SEARCH

SEARCH BY CITATION

References

  • 1
    Duncan WE, Glass AR, Wray HL. Estrogen regulation of the nuclear 1,25-dihydroxyvitamin D3 receptor in rat liver and kidney. Endocrinology 1991; 129:23182324.
  • 2
    Sandgren ME, Bronnegard M, DeLuca HF. Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat. Biochem Biophys Res Commun 1991; 181:611616.
  • 3
    Segura C, Alonso M, Fraga C, Garcia-Caballero T, Diéguez C, Pérez-Fernandez R. Vitamin D receptor ontogenesis in rat liver. Histochem Cell Biol 1999; 112:163167.
  • 4
    Baran DT, Milne ML. 1,25-dihydroxyvitamin D increases hepatocytes cytosolic calcium levels. A potential regulator of the D-25 hydroxylase. J Clin Invest 1986; 77:16221626.
  • 5
    Baran DT, Kelly AM. Lysophosphatidylinositol: a potential mediator of 1,25-dihydroxyvitamin D-induced increments in hepatocyte cytosolic calcium. Endocrinology 1988; 122:930934.
  • 6
    Baran DT, Quail JM, Ray R, Leszyk J, Honeyman T. Annexin II is the membrane receptor that mediates the rapid actions of 1α,25-dihydroxyvitamin D3. J Cell Biochem 2000; 78:3446.
  • 7
    & Eacute;thier C, Kestekian R, Beaulieu C, Dubé C, Havrankova J, Gascon-Barré M. Vitamin D depletion retards the normal regeneration process following partial hepatectomy in the rat. Endocrinology 1990; 126:29472959.
  • 8
    Goupil D, Éthier C, Zarnegar R, Gascon-Barré M. Hepatic expression of regeneration marker genes following partial hepatectomy in the rat. Influence of 1,25-dihydroxyvitamin D3 in hypocalcemia. J Hepatol 1997; 26:659668.
  • 9
    Rixon RH, Isaacs RJ, Whitfield JF. Control of DNA polymerase-α activity in regenerating rat liver by calcium and 1alpha,25(OH)2D3. J Cell Physiol 1989; 139:354360.
  • 10
    Sikorska M, Whitfield JF, Rixon RH. The effects of thyroparathyroidectomy and 1,25-dihydroxyvitamin D3 on changes in the activities of some cytoplasmic and nuclear protein kinases during liver regeneration. J Cell Physiol 1983; 115:297304.
  • 11
    Baran DT, Milne ML. 1,25 dihydroxyvitamin D-induced inhibition of 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro. Calcif Tissue Int 1983; 35:461464.
  • 12
    Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 1984; 74:15401544.
  • 13
    Theodoropoulos C, Demers C, Petit JL, Gascon-Barré M. High sensitivity of the rat hepatic vitamin D3-25 hydroxylase CYP27A to 1,25-dihydroxyvitamin D3 administration. Am J Physiol 2003; 284:E138E147.
  • 14
    Merke J, Milde P, Lewicka S, Hügel U, Klaus G, Mangelsdorf DJ, Haussler MR, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989; 83:19031915.
  • 15
    Manolagas SC, Yu XP, Girasole G, Bellido T. Vitamin D and the hematolymphopoietic tissue: a 1994 update. Semin Nephrol 1994; 14:129143.
  • 16
    Cao X, Ross FP, Zhang I, MacDonald PN, Chappel J, Teitelbaum SL. Cloning of the promoter for the avaian entegrin β3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3. J Biol Chem 1993; 268:2737127380.
  • 17
    Solomon C, Sebag M, White JH, Rhim J, Kremer R. Disruption of vitamin D receptor-retinoid X receptor heterodimer formation following ras transformation of human keratinocytes. J Biol Chem 1998; 273:1757317578.
  • 18
    Gascon-Barré M, Haddad P, Provencher SJ, Bilodeau S, Pecker F, Lotersztajn S, Vallieres S. Chronic hypocalcemia of vitamin D deficiency leads to lower resting intracellular calcium concentrations in rat hepatocytes. J Clin Invest 1994; 93:21592167.
  • 19
    Guguen-Guillouzo C, Campion JP, Brisset P, Glaise D, Lannois B, Bourel M, Guillouzo A. High yield preparation of isolated human adult preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol Int Rep 1982; 6:625628.
  • 20
    Knook DL, Sleyster CC. Separation of Kupffer and endothelial cells of the rat liver by centrifugal elutriation. Exp Cell Res 1976; 99:444449.
  • 21
    Néron S. Expression hépatique des gènes du facteur de croissance des hépatocytes et de son récepteur, le proto-oncogèene c-met, après administration de tétrachlorure de carbone. Influence du statut en vitamine D [M.Sc. thesis]. Montreal, Canada: Université de Montréal, 1995.
  • 22
    Paradis K, Le ONL, Russo P, St-Cyr M, Fournier H, Bu D. Characterization and response to interleukin 1 and tumor necrosis factor of immortalized murine biliary epithelial cells. Gastroenterology 1995; 109:13081315.
  • 23
    Blouin MJ, Lamy I, Loranger A, Noël M, Corlu A, Guguen-Guillouzo C, Marceau N. Specialization switch in differentiating embryonic rat liver progenitor cells in response to sodium butyrate. Exp Cell Res 1995; 217:2230.
  • 24
    Theodoropoulos C, Demers C, Delvin E, Ménard D, Gascon-Barré M. Calcitriol regulates the expression of the gene encoding all three vitamin D3 hydroxylases and the drug metabolizing enzyme CYP3A4 in the human fetal intestine. Clin Endocrinol 2003 (in press).
  • 25
    Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:52945299.
  • 26
    Chew CS, Säfsten B, Flemström G. Calcium signaling in cultured human and rat duodenal enterocytes. Am J Physiol 1998; 275:G286G304.
  • 27
    Burmester JK, Maeda N, DeLuca HF. Isolation and expression of rat 1,25-dihydroxyvitamin D3 receptor cDNA. Proc Natl Acad Sci U S A 1988; 85:10051009.
  • 28
    Ohyama Y, Noshiro M, Eggertsen G, Gotoh O, Kato Y, Bjorkhem I, Okuda K. Structural characterization of the gene encoding rat 25-hydroxyvitamin D3 24-hydroxylase. Biochemistry 1993; 32:7682.
  • 29
    Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13:24852502.
  • 30
    Bendayan M. Colloidal gold post-embedding immunocytochemistry. Prog Histochem Cytochem 1995; 29:1159.
  • 31
    Frens G. Controlled nucleation for the regulation of particle size in monodispersed gold suspensions. Nature 1973; 241:2022.
  • 32
    Kerry DM, Dwivedi PP, Hahn CN, Morris HA, Omdahl JL, May BK. Transcriptional synergism between vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase (CYP24) promoter. J Biol Chem 1996; 271:2971529721.
  • 33
    Haussler MR, Witfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998; 13:325349.
  • 34
    Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ, White JH. Regulation of gene expression by 1α,25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells. Mol Endocrinol 2001; 15:11271139.
  • 35
    Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, et al. Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxyvitamin D3. Mol Pharmacol 2001; 60:13991406.
  • 36
    Fisher JM, Wrighton SA, Watkins PB, Schmiedlin-Ren P, Calamia JC, Shen DD, Kunze KL, et al. First-pass midazolam metabolism catalyzed by 1α,25-dihydroxy vitamin D3-modified Caco-2 cell monolayers. J Pharmacol Exp Ther 1999; 289:11341142.
  • 37
    Mäkinen J, Frank C, Jyrkkärinne J, Gynther J, Carlberg C, Honkakoski P. Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol 2002; 62:366378.
  • 38
    Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002; 296:13131316.
  • 39
    Gascon-Barré M, Vallières S, Huet PM. Uptake of the hormone 1,25-dihydroxyvitamin D3 by the dog liver. Can J Physiol Pharmacol 1986; 64:699702.
  • 40
    Gascon-Barré M, Gamache M. Contribution of the biliary pathway to the homeostasis of vitamin D3 and of 1,25-dihydroxyvitamin D3. Endocrinology 1991; 129:23352344.
  • 41
    He RK, Gascon-Barré M. Influence of the vitamin D status on the early response to carcinogen exposure in the rat. J Pharmacol Exp Ther 1997; 281:464469.
  • 42
    Pourgholami MH, Akhter J, Finlay IG, Morris DL. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2. Anticancer Res 2000; 20:723728.
  • 43
    Bowman AR, Epstein S. Drug and hormone effects on vitamin D metabolism. In: FeldmanD, GlorieuxFH, PikeJW, eds. Vitamin D. San Diego: Academic, 1997:797829.
  • 44
    Gascon-Barré M, Côté MG. Effects of phenobarbital and diphenylhydantoin on acute vitamin D3 toxicity in the rat. Toxicol Appl Pharmacol 1978; 43:125135.
  • 45
    Hahn TJ, Birge SJ, Scharp CR, Avioli LV. Phenobarbital-induced alterations in vitamin D metabolism. J Clin Invest 1972; 51:741748.
  • 46
    Silver J, Neale G, Thompson GR. Effect of phenobarbitone treatment on vitamin D metabolism in mammals. Clin Sci Mol Med 1974; 46:433448.
  • 47
    Gascon-Barré M, Vallières S, Huet PM. Influence of phenobarbital on the hepatic handling of [3H]vitamin D3 in the dog. Am J Physiol 1986; 251:G627G635.
  • 48
    Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, et al. 25-hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 2001; 66:287292.
  • 49
    Thomas MG, Sylvester PA, Newcomb P, Longman RJ. Vitamin D receptor expression in colorectal cancer. J Clin Pathol 1999; 52:181183.
  • 50
    Miyaguchi S, Watanabe T. The role of vitamin D3 receptor mRNA in the proliferation of hepatocellular carcinoma. Hepatogastroenterology 2000; 47:468472.